Abstract: The present invention relates to oncolytic vaccinia viruses which have been modified to promote anti-tumor immunity and/or reduce host immunity and/or antibody response against the virus. It is based, at least in part, on the discovery that oncolytic vaccinia virus (i) bearing a genome deletion of a gene that reduces T cell immunity (interleukin-18 binding protein); (ii) treated with a sialidase enzyme which is believed to reduce TLR2 activation and therefore the antibody response; (iii) carrying a gene that enhances cytotoxic T lymphocyte induction (e.g., TRIF) and/or (iv) reduces tumor myeloid-derived suppressor cells by reducing prostaglandin E2 reduces tumor growth. Accordingly, the present invention provides for immunooncolytic vaccinia viruses and methods of using them in the treatment of cancers.
Type:
Grant
Filed:
February 19, 2016
Date of Patent:
October 25, 2022
Assignee:
UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Abstract: Disclosed are pharmaceutical compositions comprising a combination of five or more phages and a pharmaceutically acceptable carrier, as well as methods of treating, reducing, or preventing a disease caused by Mycobacterium tuberculosis in a mammal, methods of treating an antibiotic resistant infection in a mammal, and methods of treating, reducing, or preventing activation of a latent disease caused by M. tuberculosis.
Type:
Application
Filed:
April 8, 2022
Publication date:
October 20, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Graham F. Hatfull, Carlos Andrés Guerrero, Rebekah Marie Dedrick
Abstract: Methods are disclosed for dissecting a mucosa and a submucosa from a muscularis propria from a region of an esophagus of a subject. These methods include injecting submucosally into the esophagus of the subject a pharmaceutical composition comprising an extracellular matrix (ECM) hydrogel to form a cushion between the submucosa and the underlying muscularis propria at the region of the esophagus, wherein the ECM hydrogel has the following characteristics: a) a time to 50% gelation of less than 30 minutes at a temperature of about 37° C.; b) a flow viscosity suitable for infusion into the esophagus; and c) a stiffness of about 10 to about 400 Pascal (Pa). The ECM hydrogel is not a urinary bladder ECM hydrogel.
Type:
Application
Filed:
March 7, 2022
Publication date:
October 20, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Stephen Francis Badylak, Lindsey Tamiko Saldin, Juan Diego Naranjo Gutierrez
Abstract: A method of making an optical fiber-based sensor includes providing an optical fiber, and providing a sensing or protection layer on a surface of the optical fiber by an atomic layer deposition (ALD) process.
Type:
Application
Filed:
April 7, 2022
Publication date:
October 13, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Paul Richard Ohodnicki, Jung-Kun Lee, Yulin Liu, Ruishu Wright, Fei Lu, Jeffrey Wuenschell
Abstract: Graph-theoretic segmentation methods for segmenting histological structures in H&E stained images of tissues. The method rely on characterizing local spatial statistics in the images. Also, a method for quantifying intratumor spatial heterogeneity that can work with single biomarker, multiplexed, or hyperplexed immunofluorescence (IF) data. The method is holistic in its approach, using both the expression and spatial information of an entire tumor tissue section and/or spot in a TMA to characterize spatial associations. The method generates a two-dimensional heterogeneity map to explicitly elucidate spatial associations of both major and minor sub-populations.
Type:
Application
Filed:
June 27, 2022
Publication date:
October 13, 2022
Applicant:
UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Inventors:
S. CHAKRA CHENNUBHOTLA, D. LANSING TAYLOR
Abstract: Disclosed are effective, specific, and durable pain management therapies using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR-based) epigenetic modulation of endogenous pathways involved in pain.
Type:
Application
Filed:
April 11, 2022
Publication date:
October 13, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Samira Kiani, Mo Reza Ebrahimkhani, Tahere Mokhtari
Abstract: A method of making an optical fiber sensor device for distributed sensing includes generating a laser beam comprising a plurality of ultrafast pulses, and focusing the laser beam into a core of an optical fiber to form a nanograting structure within the core, wherein the nanograting structure includes a plurality of spaced nanograting elements each extending substantially parallel to a longitudinal axis of optical fiber. Also, an optical fiber sensor device for distributed sensing includes an optical fiber having a longitudinal axis, a core, and a nanograting structure within the core, wherein the nanograting structure includes a plurality of spaced nanograting elements each extending substantially parallel to the longitudinal axis of the optical fiber. Also, a distributed sensing method and system and an energy production system that employs such an optical fiber sensor device.
Type:
Grant
Filed:
March 3, 2020
Date of Patent:
October 11, 2022
Assignee:
University of Pittsburgh-Of the Commonwealth System of Higher Education
Inventors:
Peng Kevin Chen, Aidong Yan, Michael P. Buric, Paul R. Ohodnicki, Sheng Huang
Abstract: An electronic device, such as, without limitation, a perovskite solar cell or a light emitting diode, includes an assembly including at least one electronic portion or component, and a composite coating layer covering at least part of the assembly including the at least one electronic portion or component. The composite coating layer includes a polymer material, such as, without limitation, PMMA or PMMA-PU, having nanoparticles, such as, without limitation, reduced graphene oxide or SiO2, embedded therein. The electronic device may further include a second coating layer including a second polymer material (such as, without limitation, PMMA or PMMA-PU without nanoparticles) positioned between the coating layer and the assembly.
Type:
Grant
Filed:
December 2, 2020
Date of Patent:
October 11, 2022
Assignees:
University of Pittsburgh-Of the Commonwealth System of Higher Education, Global Frontier Center for Multiscale Enery Systems
Abstract: A method of restoring lysosomal function of retinal pigment epithelial (RPE) cells and a method of preventing and/or treating age-related macular degeneration (AMD), Stargardt's macular retinal degeneration, neurodegenerative disease, or diabetic retinopathy in a subject are provided. The methods comprise administering (i) a nucleic acid encoding a polypeptide comprising a constitutively active form of transcription factor EB (TFEB) or (ii) the polypeptide to a subject in need thereof. Associated polypeptides, nucleic acids, vectors, and compositions thereof also are provided.
Type:
Application
Filed:
March 6, 2020
Publication date:
October 6, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Abstract: The invention provides modified griffithsin polypeptides comprising the amino acid sequence of SEQ ID NO: 1, as well as corresponding nucleic acids, vectors, cells, fusion proteins, constructs, conjugates, and methods of inhibiting viral infection.
Type:
Application
Filed:
April 19, 2022
Publication date:
October 6, 2022
Applicants:
The United States of America,as represented by the Secretary,Department of Health and Human Services, University of Louisville Research Foundation, Inc., University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Barry R. O'Keefe, Tinoush Moulaei, Kenneth E. Palmer, Lisa C. Rohan, Joshua L. Fuqua, Lindsay F. Kramzer
Abstract: Administration via inhalation of small peptides that mimic CXCL10 (FIBROKINE™ peptides) is described. The peptides can be administered as an aerosol, such as an aerosol with a droplet size small enough to reach lung alveoli. Use of the peptides to treat fibrosis, such as lung fibrosis, is described.
Type:
Application
Filed:
September 10, 2020
Publication date:
October 6, 2022
Applicants:
University of Pittsburgh - Of the Commonwealth System of Higher Education, Tuskegee University
Inventors:
Cecelia C. Yates, Timothy E. Corcoran, Zariel I. Johnson, Jesse Jaynes
Abstract: Methods for the treatment of lung injury caused by chemical inhalation, smoke inhalation or microbial infection are described. The methods include administering a therapeutically effective amount of nitrite or a nitrite formulation. Nitrite formulations that include a nitrite salt and an anti-caking agent, such as sodium bicarbonate, and the use of such formulations, is also described.
Type:
Application
Filed:
September 4, 2020
Publication date:
September 29, 2022
Applicants:
University of Pittsburgh - Of the Commonwealth System of Higher Education, The UAB Research Foundation
Inventors:
Jason Joseph Rose, Mark Thomas Gladwin, Rakesh P. Patel, Sadis Matalon
Abstract: A method comprising treating a periocular wound in a subject, comprising topically administering to the periocular wound a composition comprising at least one thermoresponsive gel.
Type:
Application
Filed:
June 2, 2022
Publication date:
September 22, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Morgan V. Fedorchak, Jenny Yu, Michael A. Washington
Abstract: A method for treating an ocular disorder in a subject comprising administering a therapeutic agent-loaded carrier to an ocular site of the subject in need thereof, wherein the therapeutic agent loaded-carrier provides controlled delivery of the therapeutic agent under conditions suitable for recruiting regulatory T cells to an ocular region of interest or inducing regulatory T cells in an ocular region of interest.
Type:
Application
Filed:
June 7, 2022
Publication date:
September 22, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Steven R. Little, Michelle L. Guaragno, Andrew J. Glowacki, Morgan V. Fedorchak, Stephen C. Balmert
Abstract: Provided herein is a method for identifying cytotoxic T cell activity due to cancer immunotherapy in a subject. In some embodiments, the method comprises administering an effective amount of a tracer for positron emission tomography (PET) or single photon emission computed tomography (SPECT) to a subject receiving a cancer immunotherapy, wherein the tracer comprises an antibody or antigen-binding fragment thereof that specifically binds to a luminal domain of a lymphocytic granule-associated molecule (LGAM) labeled with a PET or SPECT detectable moiety, and detecting the signal of the tracer by PET or SPECT imaging to identify the cytotoxic T cell activity due to immune therapy for the cancer in the subject. In several embodiments, the antibody or antigen binding fragment specifically binds to the luminal domain of CD107a.
Type:
Application
Filed:
March 3, 2022
Publication date:
September 22, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
Carolyn Anderson, Wilson Edwards, Gary Kohanbash
Abstract: Disclosed herein are methods of using relaxin polypeptides and analogs, or nucleic acid molecules encoding such polypeptides to treat or inhibit atrial fibrillation.
Type:
Application
Filed:
November 5, 2021
Publication date:
September 15, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Inventors:
David S. Schwartzman, Sanjeev G. Shroff, Guy Salama, Charles F. McTiernan
Abstract: The present invention relates to methods and compositions for transplanting non-lymphoid tissues into lymphoid organs. It may be used to cultivate organ tissues including for the purpose of supplementing or reconstituting organ function. Tissues that may be propagated in this manner include but are not limited to lung, kidney, thyroid, intestine, and brain.
Type:
Application
Filed:
October 29, 2021
Publication date:
September 15, 2022
Applicant:
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Abstract: The present invention relates to methods of treating cancer patients carrying one or more specific fusion genes. It is based, at least in part, on the discovery that the protein encoded by the MAN2A1-FER fusion gene exhibits kinase activity and the use of tyrosine kinase inhibitors targeting MAN2A1-FER in a cancer other than prostate, for example hepatocellular cancer, led to dramatic improvement of survival of animals xenografted with the cancer.
Type:
Application
Filed:
May 23, 2022
Publication date:
September 15, 2022
Applicant:
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Inventors:
Jianhua LUO, Zhanghui CHEN, Yanping YU, George MICHALOPOULOS, Joel B. NELSON
Abstract: Disclosed herein are systems, methods, and devices for sensing touch at a surface. Sensing touch can be achieved while decreasing the number of sensors at a surface as well as data and computation complexity, but maintaining accuracy. Such sensing touch can be achieved via applying excitation and detecting emission waveforms at a surface that are associated with touch at a surface.
Type:
Application
Filed:
August 6, 2020
Publication date:
September 1, 2022
Applicant:
University of Pittsburgh - Of the Commonwealth System of Higher Education
Abstract: Disclosed is a method for treating or preventing nephrogenic diabetes insipidus (NDI) in a subject that includes administering to the subject a therapeutically effective amount of a Nuclear factor-erythroid 2-related factor 2 (Nrf2) inducer, thereby treating or preventing the NDI in the subject. The Nrf2 inducer may be a fumarate, a nitro fatty acid, a bardoxolone or sulforaphane. Also disclosed is a pharmaceutical composition comprising (i) a Nuclear factor-crythroid 2-related factor 2 (Nrf2) inducer and (ii) lithium or a lithium salt.
Type:
Application
Filed:
July 22, 2020
Publication date:
September 1, 2022
Applicant:
University Of Pittsburgh-Of The Commonwealth System Of Higher Education
Inventors:
Francisco J. Schopfer, Dario A. Vitturi Iglesias, Soma Jobbagy